Alice Teele, a lab technician at TickReport in Amherst, Massachusetts, holds a tiny vial containing a tick sent in from somewhere in the world—a routine arrival at a place that has become a beacon of clarity in the uncertainty of tick-borne illness.
The moment a tick latches on, the clock starts ticking in two ways. Doctors cannot immediately confirm Lyme disease through blood tests, since antibodies typically take about two weeks to develop after infection. The patient is left guessing, watching for a rash that only 70% to 80% of infected people actually develop, or monitoring for fatigue, fever and headaches—symptoms that overlap with dozens of other illnesses. But the tick itself may hold the answer, which is why TickReport and similar labs have become part of the calculus of tick-bite response.
Founded at UMass Amherst in 2006 and now operating as an independent business, TickReport uses polymerase chain reaction, or PCR—the same technology behind COVID-19 and flu tests—to detect whether a tick carries Borrelia bacteria, the pathogen that causes Lyme disease. The process is elegant: PCR rapidly copies the DNA and RNA in a tick, allowing scientists to compare those sequences against known Lyme disease agents. Results come within three business days. Pricing ranges from $60 for a DNA test to $200 for comprehensive testing that screens for Lyme disease, Rocky Mountain spotted fever, Powassan virus and other tick-borne illnesses.
Yet the appeal of certainty comes with important caveats. Stephen Rich, a professor of microbiology at UMass Amherst and director of TickReport, is blunt about what the test actually reveals: "It's not a diagnosis. It's not telling you, no, you don't have Lyme disease. What it's saying is that tick that just bit you, it had the agent that causes Lyme disease."
This distinction matters enormously. A positive result does not mean infection has occurred. Roughly 50% of adult blacklegged ticks and 30% of nymphs naturally carry Borrelia bacteria. Transmission requires the tick to remain engorged for at least 24 hours—some experts argue 36 to 48 hours is the realistic minimum. A tick that was visibly loose or appeared attached for less than a day presents minimal infection risk, even if infected.
The CDC explicitly recommends against tick testing, citing a critical timing problem: results arrive too late to take doxycycline or prophylactic antibiotics, which must be administered quickly after a potential exposure. Testing may also discourage people from seeking medical follow-up if results come back negative—though negative results can be false. The three-business-day turnaround is particularly problematic if a tick bite occurs on Friday.
Thomas Mather, director of the University of Rhode Island's Center for Vector-Borne Disease, offers an alternative. His TickEncounter Resource Center uses photo identification and human expertise, providing replies within 24 hours. This approach sidesteps unnecessary testing costs and worry—particularly important since many people cannot distinguish between blacklegged ticks, lone star ticks, and American dog ticks, the latter two of which do not transmit Lyme disease.
Tick testing is not useless; it contributes valuable epidemiological data for disease surveillance. But as Rich and Mather both suggest, it works best not as a diagnostic tool, but as one piece of information in a larger conversation between patient and doctor about risk, timing, and next steps.